Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Communicating about COVID-19 vaccine development and safety

View ORCID ProfileAlistair Thorpe, View ORCID ProfileAngela Fagerlin, Jorie Butler, View ORCID ProfileVanessa Stevens, Frank A. Drews, View ORCID ProfileHolly Shoemaker, View ORCID ProfileMarian Riddoch, Laura D. Scherer
doi: https://doi.org/10.1101/2021.06.25.21259519
Alistair Thorpe
1Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alistair Thorpe
  • For correspondence: alistair.thorpe{at}hsc.utah.edu
Angela Fagerlin
2Salt Lake City VA Informatics Decision-Enhancement and Analytic Sciences (IDEAS) Center for Innovation
1Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Angela Fagerlin
Jorie Butler
3Veterans Affairs Medical Center, Geriatric Research Education and Clinical Center (GRECC), Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center of Innovation
4Department of Internal Medicine, Division of Geriatrics, University of Utah, Salt Lake City, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanessa Stevens
5Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT
6Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vanessa Stevens
Frank A. Drews
7George Wahlen VA Medical Center Salt Lake City, UT
8Department of Psychology, University of Utah, Salt Lake City
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Holly Shoemaker
9IDEAS Center of Innovation, Veterans’ Affairs Salt Lake City Health Care System, Salt Lake City, Utah
10Department of Population Health Sciences, School of Medicine, University of Utah
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Holly Shoemaker
Marian Riddoch
11School of Medicine, University of Utah, Salt Lake City, UT
B.S.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marian Riddoch
Laura D. Scherer
12Division of Cardiology, University of Colorado, School of Medicine, Aurora, CO
13Denver VA Center of Innovation
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Purpose Beliefs that the risks from the vaccine outweigh the risks from getting COVID-19 and concerns that the vaccine development process was rushed and lacking rigor have been identified as important drivers of hesitancy and refusal to get a COVID-19 vaccine. We tested whether messages designed to address these beliefs and concerns might promote intentions to get a COVID-19 vaccine.

Method An online survey fielded between March 8-March 23, 2021 with US Veteran (n=688) and non-Veteran (n=387) respondents. In a between-subjects experiment, respondents were randomly assigned to a control group (with no message) or to read one of two intervention messages: 1. a fact-box styled message comparing the risks of getting COVID-19 compared to the vaccine, and 2. a timeline styled message describing the development process of the COVID-19 mRNA vaccines.

Results Most respondents (60%) wanted a COVID-19 vaccine. However, 17% expressed hesitancy and 23% did not want to get a COVID-19 vaccine. The fact-box styled message and the timeline message did not significantly improve vaccination intentions, F(2,358)=0.86, p=.425, Embedded Image, or reduce the time respondents wanted to wait before getting vaccinated, F(2,306)=0.79, p=.453, Embedded Image, compared to no messages.

Discussion We did not find an impact on vaccine intention based on providing information about vaccine risks and development. Further research is needed to identify how to effectively address concerns about the risks associated with COVID-19 vaccines and the development process and to understand additional factors that influence vaccine intentions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Dr. Thorpe was supported by grant No. 51300302 from the American Heart Association Childrens Strategically Focused Research Network fellowship. Funding for the study was provided by the VA (VA C-19-20-205 for recruitment of Veterans) to Drs. Fagerlin and Scherer and Dr. Fagerlins Jon M. Huntsman Presidential Endowed Chair (for recruitment of non-Veterans).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the IRBs at the University of Utah and the Salt Lake City VA (deemed exempt)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data and study materials are available from the first author upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 29, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Communicating about COVID-19 vaccine development and safety
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Communicating about COVID-19 vaccine development and safety
Alistair Thorpe, Angela Fagerlin, Jorie Butler, Vanessa Stevens, Frank A. Drews, Holly Shoemaker, Marian Riddoch, Laura D. Scherer
medRxiv 2021.06.25.21259519; doi: https://doi.org/10.1101/2021.06.25.21259519
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Communicating about COVID-19 vaccine development and safety
Alistair Thorpe, Angela Fagerlin, Jorie Butler, Vanessa Stevens, Frank A. Drews, Holly Shoemaker, Marian Riddoch, Laura D. Scherer
medRxiv 2021.06.25.21259519; doi: https://doi.org/10.1101/2021.06.25.21259519

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3292)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13374)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3268)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14627)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)